Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Global Inc Regulatory News (CMPI)

Share Price Information for Ct Global Inc (CMPI)

Share Price is delayed by 15 minutes
Get Live Data
131.50    0.00 (0.00%)
Bid:
129.00
Ask:
134.00
Spread: 5.00 (3.876%)
Market Cap: £124.74m
CMPI Live PriceLast checked at - London Stock Exchange

Intraday Ct Global Inc Share Chart

Transaction in Own Shares

3 Oct 2025 16:50

RNS Number : 0718C
CT Global Managed Portfolio - CMPI
03 October 2025
 

TO: RNS

FROM: CT Global Managed Portfolio Trust PLC

DATE: 3 October 2025

SUBJECT: Transaction in own shares

LEI: 213800ZA6TW45NM9YY31

 

 

The Board of CT Global Managed Portfolio Trust PLC ("the Company") announces that on 3 October 2025 the Company purchased 25,000 Growth shares of £0.046131176 each at a price of 280.0p per Growth share to be held in treasury.

 

Following this transaction the Company's issued share capital consists of 54,540,518 Income shares and 38,741,161 Growth shares, of which nil Income shares and 5,578,000 Growth shares are held in treasury. Therefore the total number of shares with voting rights in CT Global Managed Portfolio Trust PLC is 54,540,518 Income shares and 33,163,161 Growth shares.

 

The above figures (54,540,518 Income shares and 33,163,161 Growth shares) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CT Global Managed Portfolio Trust PLC under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Adam Norris, Columbia Threadneedle Investment Business Limited 0131 573 8360

Paul Green, Columbia Threadneedle Investment Business Limited 0131 573 8360

Ian Ridge, Columbia Threadneedle Investment Business Limited 0131 573 8316

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEXLFBEBLZFBK
Date   Source Headline
9th Feb 202612:32 pmRNSNet Asset Value(s)
6th Feb 202612:46 pmRNSNet Asset Value(s)
5th Feb 202612:47 pmRNSNet Asset Value(s)
4th Feb 202612:56 pmRNSNet Asset Value(s)
3rd Feb 202612:39 pmRNSNet Asset Value(s)
2nd Feb 20262:31 pmRNSIssue of Equity
2nd Feb 20261:00 pmRNSTotal Voting Rights
2nd Feb 202612:40 pmRNSNet Asset Value(s)
30th Jan 20264:15 pmRNSIssue of Equity
30th Jan 20261:05 pmRNSDoc re. Half Year Report
30th Jan 202612:48 pmRNSNet Asset Value(s)
30th Jan 20267:00 amRNSHalf Year Report to 30 November 2025
29th Jan 202612:43 pmRNSNet Asset Value(s)
28th Jan 202612:30 pmRNSNet Asset Value(s)
27th Jan 202612:52 pmRNSNet Asset Value(s)
26th Jan 202612:44 pmRNSNet Asset Value(s)
23rd Jan 202612:53 pmRNSNet Asset Value(s)
22nd Jan 202612:34 pmRNSNet Asset Value(s)
21st Jan 202612:55 pmRNSNet Asset Value(s)
20th Jan 202612:31 pmRNSNet Asset Value(s)
20th Jan 20269:58 amRNS-RInvestor Presentation
19th Jan 20264:23 pmRNSIssue of Equity
19th Jan 202612:33 pmRNSNet Asset Value(s)
16th Jan 20263:44 pmRNSIssue of Equity
16th Jan 202612:35 pmRNSNet Asset Value(s)
15th Jan 202612:04 pmRNSNet Asset Value(s)
14th Jan 202612:04 pmRNSNet Asset Value(s)
13th Jan 20264:55 pmRNSIssue of Equity
13th Jan 202612:47 pmRNSNet Asset Value(s)
12th Jan 20264:39 pmRNSIssue of Equity
12th Jan 202612:52 pmRNSNet Asset Value(s)
9th Jan 202612:42 pmRNSNet Asset Value(s)
8th Jan 20261:03 pmRNSNet Asset Value(s)
7th Jan 20264:11 pmRNSIssue of Equity
7th Jan 202612:34 pmRNSNet Asset Value(s)
6th Jan 20264:32 pmRNSIssue of Equity
6th Jan 202612:15 pmRNSNet Asset Value(s)
5th Jan 202612:58 pmRNSNet Asset Value(s)
2nd Jan 20263:47 pmRNSIssue of Equity
2nd Jan 202612:46 pmRNSNet Asset Value(s)
2nd Jan 202612:33 pmRNSTotal Voting Rights
31st Dec 20251:34 pmRNSChair of the Marketing Committee
31st Dec 20251:34 pmRNSChair of the Marketing Committee
31st Dec 202512:56 pmRNSNet Asset Value(s)
30th Dec 20253:04 pmRNSIssue of Equity
30th Dec 20253:04 pmRNSIssue of Equity
30th Dec 202512:36 pmRNSNet Asset Value(s)
29th Dec 20254:39 pmRNSIssue of Equity
29th Dec 20254:39 pmRNSIssue of Equity
29th Dec 20251:34 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.